Literature DB >> 19128923

Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas.

J K Pine1, K G Fusai, R Young, D Sharma, B R Davidson, K V Menon, S H Rahman.   

Abstract

BACKGROUND: The prognostic role of serum C-reactive protein in pancreatic cancer has received increasing attention; however the confounding effects of biliary obstruction have not been addressed in previous studies. We sought to determine the prognostic importance of serum CRP prior to biliary intervention in the prognosis of pancreatic adenocarcinoma.
METHODS: A retrospective case note review of patients diagnosed with pancreatic cancer between 2001 and 2006. Clinical, radiological and biochemical criteria were correlated with overall survival. Patients were divided into: Group 1 who underwent potentially curative resection, and Group 2 with advanced unresectable disease managed non-surgically.
RESULTS: In total, 199 patients were included (58 resected). The proportion of patients with biliary obstruction was equal in both groups. Serum CRP and serum bilirubin concentration at presentation were significantly higher among patients in Group 2 compared to Group 1 (P values). On multivariate analysis, advancing age (P=0.012) and raised serum CRP concentration were independently associated with overall survival only in Group 2 patients (P=0.027, 95% CI 0.31-0.93). This association was independent of biliary tract obstruction.
CONCLUSION: Raised serum C-reactive protein concentration at the time of presentation of advanced pancreatic cancer carries a poor prognosis independent of biliary tract obstruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19128923     DOI: 10.1016/j.ejso.2008.12.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  32 in total

1.  Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer.

Authors:  Jai Young Cho; Ho-Seong Han; Yoo-Seok Yoon; Dae Wook Hwang; Kyuwhan Jung; Ji Hoon Kim; Yujin Kwon; Haeryoung Kim
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma.

Authors:  G Garcea; N Ladwa; C P Neal; M S Metcalfe; A R Dennison; D P Berry
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

Review 3.  Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma.

Authors:  Wilson Petrushnko; Justin S Gundara; Philip R De Reuver; Greg O'Grady; Jaswinder S Samra; Anubhav Mittal
Journal:  HPB (Oxford)       Date:  2016-07-14       Impact factor: 3.647

4.  Prevalence of systemic inflammation and micronutrient imbalance in patients with complex abdominal hernias.

Authors:  Abby K Geletzke; John M Rinaldi; Brett E Phillips; Sarah B Mobley; Jamie Miller; Thomas Dykes; Christopher Hollenbeak; Shannon L Kelleher; David I Soybel
Journal:  J Gastrointest Surg       Date:  2013-12-20       Impact factor: 3.452

5.  Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.

Authors:  Jason B Douglas; Debra T Silverman; Stephanie J Weinstein; Barry I Graubard; Michael N Pollak; Yuzhen Tao; Jarmo Virtamo; Demetrius Albanes; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

Review 6.  Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review.

Authors:  Lewis Stevens; Samir Pathak; Quentin M Nunes; Sanjay Pandanaboyana; Christian Macutkiewicz; Neil Smart; Andrew M Smith
Journal:  HPB (Oxford)       Date:  2014-11-27       Impact factor: 3.647

7.  High serum level of C-reactive protein is associated with worse outcome of patients with advanced-stage NSCLC treated with erlotinib.

Authors:  Ondrej Fiala; Milos Pesek; Jindrich Finek; Ondrej Topolcan; Jaroslav Racek; Marek Minarik; Lucie Benesova; Zbynek Bortlicek; Alexandr Poprach; Tomas Buchler
Journal:  Tumour Biol       Date:  2015-06-19

8.  C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin.

Authors:  Marcel C G van de Poll; Yvonne L B Klaver; Valery E P P Lemmens; Bart J M Leenders; Simon W Nienhuijs; Ignace H J T de Hingh
Journal:  Int J Colorectal Dis       Date:  2011-04-08       Impact factor: 2.571

9.  Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

Authors:  A Xue; C J Scarlett; L Chung; G Butturini; A Scarpa; R Gandy; S R Wilson; R C Baxter; R C Smith
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

10.  Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.

Authors:  Michael Haas; Volker Heinemann; Frank Kullmann; Rüdiger P Laubender; Christina Klose; Christiane J Bruns; Stefan Holdenrieder; Dominik P Modest; Christoph Schulz; Stefan Boeck
Journal:  J Cancer Res Clin Oncol       Date:  2013-01-13       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.